Literature DB >> 10636887

A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation.

H M Wright1, C B Clish, T Mikami, S Hauser, K Yanagi, R Hiramatsu, C N Serhan, B M Spiegelman.   

Abstract

While searching for natural ligands for the peroxisome proliferator-activated receptor (PPAR) gamma, we identified a synthetic compound that binds to this receptor. Bisphenol A diglycidyl ether (BADGE) is a ligand for PPARgamma with a K(d(app)) of 100 microM. This compound has no apparent ability to activate the transcriptional activity of PPARgamma; however, BADGE can antagonize the ability of agonist ligands such as rosiglitazone to activate the transcriptional and adipogenic action of this receptor. BADGE also specifically blocks the ability of natural adipogenic cell lines such as 3T3-L1 and 3T3-F442A cells to undergo hormone-mediated cell differentiation. These results provide the first pharmacological evidence that PPARgamma activity is required for the hormonally induced differentiation of adipogenic cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10636887     DOI: 10.1074/jbc.275.3.1873

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  94 in total

1.  Rapid signaling actions of environmental estrogens in developing granule cell neurons are mediated by estrogen receptor ß.

Authors:  Hoa H Le; Scott M Belcher
Journal:  Endocrinology       Date:  2010-10-06       Impact factor: 4.736

2.  Relationship between urinary bisphenol A levels and diabetes mellitus.

Authors:  Anoop Shankar; Srinivas Teppala
Journal:  J Clin Endocrinol Metab       Date:  2011-09-28       Impact factor: 5.958

3.  AMPK enhances the expression of pancreatic duodenal homeobox-1 via PPARalpha, but not PPARgamma, in rat insulinoma cell line INS-1.

Authors:  Hua Guo; Shui Sun; Xu Zhang; Xiu-juan Zhang; Ling Gao; Jia-jun Zhao
Journal:  Acta Pharmacol Sin       Date:  2010-07-19       Impact factor: 6.150

4.  Epo receptor signaling in macrophages alters the splenic niche to promote erythroid differentiation.

Authors:  Yuanting Chen; Jie Xiang; Fenghua Qian; Bastihalli T Diwakar; Baiye Ruan; Siyang Hao; K Sandeep Prabhu; Robert F Paulson
Journal:  Blood       Date:  2020-07-09       Impact factor: 22.113

5.  Identification of a peroxisome-proliferator-activated-receptor response element in the apolipoprotein E gene control region.

Authors:  R Galetto; M Albajar; J I Polanco; M M Zakin; J C Rodríguez-Rey
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

6.  Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma.

Authors:  L Chastine Bell-Parikh; Tomomi Ide; John A Lawson; Peter McNamara; Muredach Reilly; Garret A FitzGerald
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

7.  Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.

Authors:  Salvatore Cuzzocrea; Barbara Pisano; Laura Dugo; Angela Ianaro; Nimesh S A Patel; Rosanna Di Paola; Tiziana Genovese; Prabal K Chatterjee; Massimo Di Rosa; Achille P Caputi; Christoph Thiemermann
Journal:  Br J Pharmacol       Date:  2003-08-11       Impact factor: 8.739

Review 8.  Fat-bone interaction within the bone marrow milieu: Impact on hematopoiesis and systemic energy metabolism.

Authors:  C P Hawkes; S Mostoufi-Moab
Journal:  Bone       Date:  2018-03-15       Impact factor: 4.398

9.  Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.

Authors:  Venkatesh L Hegde; Udai P Singh; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

10.  Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats.

Authors:  Sajay B Churi; Omar S Abdel-Aleem; Kiranjeet K Tumber; Heather Scuderi-Porter; Bradley K Taylor
Journal:  J Pain       Date:  2008-04-03       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.